Richard D Carvajal


Ontology type: schema:Person     


Person Info

NAME

Richard D

SURNAME

Carvajal

Publications in SciGraph latest 50 shown

  • 2022-09-04 Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd – 4th, 2021, Italy) in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2022-08-23 Clinical and genomic correlates of imatinib response in melanomas with KIT alterations in BRITISH JOURNAL OF CANCER
  • 2022-06-29 First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2022-03-02 New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma in CANCER GENE THERAPY
  • 2022-01-17 Author Correction: Uveal melanoma in NATURE REVIEWS DISEASE PRIMERS
  • 2021-08-16 Multiregional genetic evolution of metastatic uveal melanoma in NPJ GENOMIC MEDICINE
  • 2021-04-14 A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2021-02-23 LY3022855, an anti–colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial in INVESTIGATIONAL NEW DRUGS
  • 2020-09-30 Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial in EUROPEAN RADIOLOGY
  • 2020-09-07 Perspectives in melanoma: meeting report from the “Melanoma Bridge” (December 5th–7th, 2019, Naples, Italy) in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2020-07-28 Novel Approaches to the Systemic Management of Uveal Melanoma in CURRENT ONCOLOGY REPORTS
  • 2020-04-09 Uveal melanoma in NATURE REVIEWS DISEASE PRIMERS
  • 2020-01-29 Systemic Therapy for Mucosal, Acral, and Uveal Melanoma in CUTANEOUS MELANOMA
  • 2020-01-21 Conjunctival Melanoma: Current Treatments and Future Options in AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
  • 2019-11-15 Dual checkpoint inhibitor-associated eosinophilic enteritis in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2019-11-06 Novel Targets for the Treatment of Melanoma in CURRENT ONCOLOGY REPORTS
  • 2019-06-29 Uveal Melanoma: Adjuvant Therapy in CLINICAL OPHTHALMIC ONCOLOGY
  • 2019-02-26 Systemic Therapy for Mucosal, Acral and Uveal Melanoma in CUTANEOUS MELANOMA
  • 2019-02-01 KIT as an Oncogenic Driver in Melanoma: An Update on Clinical Development in AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
  • 2018-09-25 Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-11-11 A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma in INVESTIGATIONAL NEW DRUGS
  • 2017-07-15 Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2017-05-16 Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies in CURRENT ONCOLOGY REPORTS
  • 2017-03-01 Patient perspectives on ipilimumab across the melanoma treatment trajectory in SUPPORTIVE CARE IN CANCER
  • 2016-12-05 Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2016-04-19 Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-11-25 Treatment of Uveal Melanoma in MELANOMA
  • 2015-06-16 Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-06-10 Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT) in BMC CANCER
  • 2015-02-12 Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2014-10-14 Ipilimumab in patients with melanoma and autoimmune disease in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11-18 Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-10-31 Selecting Patients for KIT Inhibition in Melanoma in MOLECULAR DIAGNOSTICS FOR MELANOMA
  • 2013-07-10 Prognosis of Acral Melanoma: A Series of 281 Patients in ANNALS OF SURGICAL ONCOLOGY
  • 2013-01-18 Locoregional Lymphadenectomy in the Surgical Management of Anorectal Melanoma in ANNALS OF SURGICAL ONCOLOGY
  • 2012-08-05 Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma in INVESTIGATIONAL NEW DRUGS
  • 2012-06-04 Mucosal Melanoma: Pathogenesis, Clinical Behavior, and Management in CURRENT ONCOLOGY REPORTS
  • 2012-06-02 Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2010-05-12 A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2010-02-21 A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.21729.3f", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.25879.31", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416477.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413734.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.137628.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239585.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410718.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412468.d", 
            "type": "Organization"
          }
        ], 
        "familyName": "Carvajal", 
        "givenName": "Richard D", 
        "id": "sg:person.0726366600.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726366600.25"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-10-01T07:17", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/person/person_715.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0726366600.25'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0726366600.25'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0726366600.25'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0726366600.25'


     

    This table displays all metadata directly associated to this object as RDF triples.

    34 TRIPLES      10 PREDICATES      20 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0726366600.25 schema:affiliation Nbaaa989032ce4274a843faa02b8a2aa9
    2 grid-institutes:grid.137628.9
    3 grid-institutes:grid.239585.0
    4 grid-institutes:grid.25879.31
    5 grid-institutes:grid.410718.b
    6 grid-institutes:grid.412468.d
    7 grid-institutes:grid.413734.6
    8 grid-institutes:grid.416477.7
    9 grid-institutes:grid.51462.34
    10 grid-institutes:grid.5386.8
    11 schema:familyName Carvajal
    12 schema:givenName Richard D
    13 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726366600.25
    14 schema:sdDatePublished 2022-10-01T07:17
    15 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    16 schema:sdPublisher Na892db80c1ce4381934821972f837d0b
    17 sgo:license sg:explorer/license/
    18 sgo:sdDataset persons
    19 rdf:type schema:Person
    20 Na892db80c1ce4381934821972f837d0b schema:name Springer Nature - SN SciGraph project
    21 rdf:type schema:Organization
    22 Nbaaa989032ce4274a843faa02b8a2aa9 schema:affiliation grid-institutes:grid.21729.3f
    23 sgo:isCurrent true
    24 rdf:type schema:OrganizationRole
    25 grid-institutes:grid.137628.9 schema:Organization
    26 grid-institutes:grid.21729.3f schema:Organization
    27 grid-institutes:grid.239585.0 schema:Organization
    28 grid-institutes:grid.25879.31 schema:Organization
    29 grid-institutes:grid.410718.b schema:Organization
    30 grid-institutes:grid.412468.d schema:Organization
    31 grid-institutes:grid.413734.6 schema:Organization
    32 grid-institutes:grid.416477.7 schema:Organization
    33 grid-institutes:grid.51462.34 schema:Organization
    34 grid-institutes:grid.5386.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...